Related Experiment Video
Updated: Mar 24, 2026

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
Pulmonary hypertension
Anton Vonk Noordegraaf1, Joanne A Groeneveldt2, Harm Jan Bogaard2
1Dept of Pulmonary Medicine, VU University Medical Center, Amsterdam, The Netherlands A.vonk@vumc.nl.
This review highlights key 2015 research on pulmonary hypertension, focusing on diagnosis and combination therapy
Area of Science:
- Pulmonary Hypertension Research
- Vascular Biology
- Cardiology
Background:
- Over 800 papers on pulmonary hypertension were published in 2015.
- European guidelines offer a comprehensive summary of existing clinical studies.
- A selective review is necessary to cover recent advancements.
Purpose of the Study:
- To review significant clinical studies on pulmonary hypertension published after the European guidelines.
- To summarize recent breakthroughs in pulmonary vasculature science.
- To focus on pulmonary arterial hypertension diagnosis and combination therapy's impact on the right ventricle.
Main Methods:
- Selective review of post-guideline publications from 2015.
- Analysis of scientific advancements in pulmonary vasculature.
- Focus on diagnostic criteria and therapeutic outcomes.
Main Results:
- Key findings from selected 2015 pulmonary hypertension studies are presented.
- Recent scientific breakthroughs in understanding pulmonary vasculature are summarized.
- The efficacy of combination therapy on right ventricular function is discussed.
Conclusions:
- This review provides a focused overview of critical 2015 pulmonary hypertension research.
- It highlights advancements in diagnosis and the impact of combination therapy.
- The selection reflects a curated perspective on impactful research in the field.
More Related Videos
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Pulmonary Embolism I: Introduction
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...

